Form 4: Novavax Director Richard J. Rodgers Reports Stock Transaction
SEC Form 4
Director Richard J. Rodgers reports a transaction involving Novavax Inc. common stock and Restricted Stock Units (RSUs) on October 29, 2024.
Summary
- Richard J. Rodgers, a director of Novavax Inc., reported a transaction on October 29, 2024.
- The transaction involved the disposition of 3,800 shares of common stock.
- The transaction also involved Restricted Stock Units (RSUs).
- Following the reported transaction, Rodgers directly owns 3,800 derivative securities.
- One-third of the RSUs vest on each of the first three anniversaries of the grant date, contingent upon continued employment.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of insider transactions, required by the SEC to ensure transparency and prevent insider trading. It provides investors with information about the trading activities of company insiders.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects an insider's trading activity.
Key Dates
| Date | Description |
|---|---|
| 10/29/2024 | Date of transaction involving common stock and Restricted Stock Units. |
| 10/29/2032 | Expiration date of Restricted Stock Units. |
| 10/31/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.